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Hypertension (HT) is one of the major diseases associated with the circulatory system 
and remains a public health problem with a high rate of prevalence in the adult 
population in the USA. The pressure natriuresis mechanism which is Na+ excretion in 
respond to rise in blood pressure acts as a long-term regulator of arterial blood 
pressure. Recent studies have demonstrated that impairment of this long-term pressure 
natriuresis mechanism is involved in hypertension (HT) and many other renal disorders. 
Exercise is a nonpharmacological treatment to help control HT, and exercise has a 
beneficial effect on vascular health, endothelial functions, arterial stiffness, blood 
pressure, and VO₂ max (49). Since exercise is beneficial to hypertensive patients, it is 
important to understand the relationship between exercise and pressure natriuresis. The 
goal of this study was to determine if voluntary exercise in young spontaneously 
hypertensive female and male rats altered pressure natriuresis. Forty 4-week-old SHR 
(Twenty female and Twenty male) were randomly assigned into two treatment groups, 
exercise and sedentary. After 8 weeks, urine was collected during baseline, lowered, 
and raised renal perfusion pressures (RPPs). Urinary Na excretion was measured and 
pressure natriuresis curves (Na+ excretion vs RPP) were generated for each group. 
Exercise in female spontaneously hypertensive rats( SHRs) significantly improved the 
pressure natriuresis relationship, with the exercised female rats producing a greater 
increase in sodium excretion for any given increase in RPP. However, exercise in the 
males had no significant effect on the pressure natriuresis relationship. This study 
suggests that sex differences may play an important role in long-term pressure 
regulation and exercise performance in SHRs. Further understanding of the 
mechanisms behind this beneficial effect of exercise on pressure natriuresis may 





Hypertension and Prevalence 
Hypertension is one of the most common disorders associated with the circulatory 
system and remains a major public health problem, with a high rate of prevalence in the 
adult population in the USA. Hypertension (HT) is defined as a chronic or temporary 
elevation of arterial blood pressure (59). Arterial pressure can be divided into systolic 
and diastolic pressure. Systolic pressure occurs as blood is pumped out of the heart 
through the aorta and pulmonary trunks. Diastolic pressure occurs as the heart rests 
between heartbeats, and these pressures are elevated in HT patients (59). 
Hypertension affects more than 1.2 billion individuals worldwide, and the 2017 medical 
guidelines showed that 81.9 million people depend on antihypertensive medication, 
while non-pharmacological interventions were recommended for only 9.4% of 
hypertensive patients (47). Patients with hypertension usually have several factors that 
can affect the results of research, including drug therapies, daily living activities, and 
level of stress, which makes it difficult to perform well-controlled long-term studies in 
human beings (77). Animal models with hypertension, such as rodents, are suitable 
models for study because researchers can control their diet, drugs and activity (77). The 
developmental period of hypertension is very short in spontaneously hypertensive rats 
(SHRs) when compared to humans. SHRs develop hypertension beginning at 7 weeks 
of age, with rapidly increasing BP with aging (77).So rat models are great model 





Health Impacts and Risk Factors 
Hypertensive patients have an increased risk of stroke, heart failure, renal dysfunction, 
and other health-related problems (10, 54).  Hypertension also increases the mortality 
rate of cardiovascular disease (47) and causes severe functional and structural 
damages to the brain, which can lead to vascular dementia (10). HT can occur due to 
hereditary and environmental factors. Environmental factors include too much salt 
intake, drinking too much alcohol, smoking, less potassium intake, stress and obesity, 
sedentary lifestyle, and many chronic conditions such as renal dysfunction (2, 40,44). 
Among environmental factors, high salt intake and high Na+ concentration in the blood 
is a major risk factor of getting HT.  A high salt diet may induce changes in the vessel 
walls. High salt induce diet may also lead to alterations in collagen accumulation and 
increased vascular stiffness (30,68).   High renal fibrosis is also observed in 
hypertensive subjects, however, it becomes less severe with daily exercise or aerobic 
training (20). Vascular structural changes, endothelial dysfunctions, renal dysfunctions, 
and sympathetic overstimulation (35) are major factors that lead to the pathophysiology 
of hypertension. Artery stiffness is also a significant risk factor in hypertension and other 
cardiovascular diseases (7). Other behavioral and environmental factors are also 
related to blood pressure. People who migrate from underdeveloped to developed areas 
often have increased blood pressure due to changes in nutrition, exercise activity, and 





Epidemiology - Sex Difference 
Gender is one of the main risk factor and both men and women are prone to 
hypertension. Men are more prone to hypertension and other renal diseases than age-
matched women (12,60,64). However, studies by Pinto et. al. demonstrated that the risk 
of hypertension increased with age for both sexes (60). Sex differences in hypertension 
are based on physiological factors due to aging, sex hormones, other disease 
conditions, and behavioral factors  (4,67,60,12,51,45). 
Aging is one of the main risk factors associate with hypertension. Compared to young 
individuals, elderly people have an increased risk of cardiovascular diseases (CVD) and 
renal inflammation due to physiological changes in their bodies. The systolic blood 
pressure (SBP) rises steadily, however diastolic blood pressure (DBP) increases to a 
maximum level and becomes plateaued or decreases with aging (60). The Framingham 
heart study reported that SBP was raised between the ages of 30-84 and DBP 
decreased between the ages of  60-84. (60,69). 
Sex differences in hypertension are also associated with age.  The rise in systolic 
pressure is steeper in women compared to age-matched men (60,17).  A 25-year 
observational study in Sweden reported that (67 years ) women had a higher average 
blood pressure than younger women, whether they were hypertensive or not. However, 
hypertension in men produced a greater increase in mortality risk compared to same-
aged women (48). Young men are more prone to CVD and renal diseases than age-
matched women (60,12,21). One study found that among 18-29-year-old white 
adults,1.5%of women versus 5% percent of men have hypertension (21). The death 
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rates were doubled among hypertensive middle-aged men compared with middle-aged 
women. Hypertension is more common in middle-aged men than women (4). The 
National Health and Nutrition Examination Surveys (NHANES III)  have shown that 
normotensive and hypertensive young men have higher overall mean arterial pressure 
than women (13,56). Young women have fewer stiff arteries compared with same-aged 
men (68). Although an increase in artery stiffness occurs after menopause in women, 
rates always remain lower than in men (9,71,60,68).  Higher levels of blood pressure in 
men compared to women increase the incidence of stroke, heart failure, and renal 
dysfunctions in men. Coronary artery diseases also develop in younger aged men 
compare to women (4).  Moreover, high-density lipoprotein levels are lower in men 
(63,5) and this increases the risk of hypertension, coronary heart disease, stroke, heart 
failure, and renal disease. High-density lipoproteins lower the risk of hypertension and 
other CVD such as atherosclerosis. 
The female sex hormone, estrogen, has a cardiac protective effect, and estrogen 
modulates vascular endothelial functions (33). A study by Beckhoff et. al. found that 
ovariectomized female SHR had an increased risk of hypertension (4,19). Reckelhoff et. 
al. demonstrated that testosterone injected into the spontaneously hypertensive rat 
results in a hypertensive shift in the pressure regulation (4,19).  
Some forms of hypertension are more common in women.  Hypertension occurs more 
often in type II diabetic women than men (60,17). ISH (Isolated systolic hypertension) is 
a form of hypertension that results in a diastolic blood pressure less than 80 mmHg, but 
a systolic blood pressure higher than 130 mmHg (60). The Framingham heart study 
found a higher prevalence of ISH in older women than in older men (60). This is due to 
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stiffer arteries with a wider radius or other physiological and behavioral factors. 
However, the higher total amount of activity and weekly vigorous activity had an inverse 
association with hypertension in women (5).  
Lifestyle-related risk factors also vary between the sexes.  According to a study by 
Bethany et. al. 35% of women and 29 % of men have a healthy weight (9). This might 
be due to a healthy diet and healthy living (9). The smoking percentage was increased 
in men compared to women. However, women have lower levels of physical activity 
compared to men (36% of women and 46% of men participate in regular physical 
activity) (9). Studies also reported that women have more awareness of hypertension 
and are more likely to report their normotensive or hypertensive BP than men. Women 
have more recent doctor visits compare to men. 46% of women have seen a medical 
professional recently compared to 30% of men (9). These factors can contribute to the 
sex difference in hypertension and other cardiovascular diseases. Although both men 
and women suffer from CVD later in their life, (5,72,21) there was a preventive effect of 
leisure-time physical activity on coronary artery disease, and hypertension, regardless 
of the degree of overweight or obesity (32,18,34). 
Mean Atrial Pressure (MAP) 
The blood pressure reading is usually marked as the systolic number over the diastolic 
number. Blood pressure in normotensive individuals is around 120mmHg over 
80mmHg. A hypertensive patient will have high systolic blood pressure 
(SBP>140mmHg) and/or high diastolic blood pressure (DBP>90mmHg) (59).  Mean 
arterial pressure (MAP) is the average arterial pressure over a single cardiac cycle 
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- systole, and diastole (22). MAP is influenced by cardiac output (CO) and vascular 
resistance (VR). Cardiac output is measured as the product of heart rate (HR) 
and stroke volume(SV)(22). Increased blood volume will increase the ventricular filling 
volume, (preload), the SV, and therefore increase CO and MAP (22) Systemic vascular 
resistance is primarily determined by the diameter of the blood arterioles. Decreasing 
the diameter of an arteriole increases vascular resistance because blood must pass 
through a smaller radius vessel. Short-term regulation of MAP is under baroreceptor 
reflex control, which uses the autonomic nervous system to affect both cardiac output 
and systemic vascular resistance to maintain MAP within the proper range (22). Long-
term regulation is believed to be under the control of the renal system through blood 
volume regulation, which directly affects cardiac output (22).  
Renal Pressure Natriuresis 
 Arthur Guyton was the first to identify the role of the renal pressure mechanism in mean 
arterial pressure control (54). Pressure natriuresis is a major control mechanism for the 
regulation of body fluid volume and long-term arterial pressure or mean arterial pressure 
(54). The kidneys increase Na+ elimination when blood pressure is elevated to 
decrease blood volume, which decreases end-diastolic volume (EDV), stroke volume 
(SV), and CO (59). This eventually decreases MAP. Elevations of blood pressure at the 
kidney initiate decreased reabsorption of sodium and water by the renal tubules, and 
this results in a high Na+ concentration in the urine (natriuresis)(54). Dysfunction of this 
mechanism leads to numerous cardiovascular and renal diseases, including 
hypertension (54). The SHRs are a suitable model for examining changes in pressure 
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natriuresis because the SHR’s renal pressure natriuresis mechanism is similar to that of 
humans, and SHR also develop hypertension as they age.  
Hormone Regulation- RAAS 
The main hormone system for the regulation of intravascular volume and systemic 
blood pressure is the renin-angiotensin-aldosterone system (RAAS)(35). This RAAS 
cascade influences the kidney, lungs, vasculature, and brain (37).  This system affects 
vascular tone, sodium retention, oxidative stress, fibrosis, sympathetic tone, and 
inflammation (23).  The RAAS is responsible for chronic alterations in blood pressure 
(37). Both kidneys secrete the enzyme renin, and this is the very first step of the RAAS 
cascade. Renin converts angiotensinogen to angiotensin I.  Angiotensin I is quickly 
converted to angiotensin II by angiotensin-converting enzyme (ACE) located on the lung 
vascular endothelium (23,16).  Angiotensin II (Ang II) binds to two major receptors, type 
1 (AT1) and type 2 (AT2) receptors (58). AT1R enhances anti-natriuresis and raises BP, 
AT2R has the opposite effect of AT1R. AT2R enhances the natriuretic response and 
reduces blood pressure (15). RAAS activity is essential for long-term blood pressure 
regulation, same as the pressure natriuresis. However, RAAS is also responsible for 
elevated blood pressure in certain conditions. More importantly, RAAS blocking drugs 
have been available and commonly used in today’s medical world.  Overstimulation of 
RAAS can contribute to many CVDs and renal dysfunctions. Inhibition of ACE or renin 
concentrations can inhibit the RAAS cascade. The overall goal of inhibition of the RAA 
activity is to improve renal output and reduce cardiovascular mortality rates (23,16). The 
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RAAS cascade is affected by sex hormones, however, both sexes utilize the same 
antihypertensive drugs (73,24).  
Ang II has major effects on the kidney, adrenal gland, arterioles, and brain (37). 
Angiotensin II (Ang II) causes increased blood pressure by raising vascular resistance 
through direct vascular constriction. In addition, Ang II also stimulates extracellular 
protein synthesis by boosting the signaling activity (38), which may lead to renal fibrosis. 
High renal fibrosis is one of the risk factors for elevated blood pressure (35). The RAAS 
stimulates the synthesis of pro-inflammatory molecules and pro-fibrotic agents that 
contribute to altering the function of some organs during certain disease conditions. In 
rodents, ANG II blocking agents protect against neurodegeneration and promote 
longevity (8). Angiotensin receptor blockers are used to decrease pre-hypertension (55) 
However decreased levels of Ang II also decrease arterial resistance, which lowers 
systolic and diastolic blood pressure (20).  
Although the RAAS serves as a long-term blood pressure regulator, the RAAS can be 
activated or overstimulated due to several conditions that lead to the development of 
HT.  Overexpression of plasma renin (PRA) and aldosterone (ALDO) is common in 
obese and hypertensive people, and these increase blood volume and vascular 
resistance. High levels of ALDO have been associated with increased aortic and arterial 
stiffness which increases the systolic and diastolic blood pressures (20). In obese 
individuals, elevated plasma renin, angiotensin, and aldosterone levels cause 
vasoconstriction, and this may lead to high blood pressure (20). The RAAS also is 
involved in the SHR’s pathophysiology of renovascular hypertension. Aldo causes an 
increase in sodium reabsorption and potassium excretion at the distal tubule and 
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collecting duct of the nephron (16). Aldosterone stimulates the insertion of the Na+ 
channel/ basolateral Na-K ATPase protein (37). An increase in Na+ in the body leads to 
an increase in osmolarity and an increase in blood and extracellular fluid. This will 
increase blood pressure due to the large blood volume (37). Ang II also acts on the 
brain which stimulates thirst and the release of anti-diuretic hormone (ADH). ADH acts 
to increases water reabsorption in the kidney (16,37).  
Natriuretic Peptides 
There are 3 major natriuretic peptides found in the human body. Atrial natriuretic 
peptide (ANP), brain natriuretic peptide ( b-type) (BNP), and urodilatin (27,31,53,62). 
These peptides play an important role in intravascular blood volume and vascular tone 
regulation (53). ANP is primarily stored in atrial granules and becomes a mature peptide 
inside the circulatory system. BNP is stored in atrial granules and ventricles, and it was 
first found in the brain tissue  (61).  The kidneys produce and secrete a compound 
similar to ANP, called urodilatin (31,61,62). Urodilatin, first discovered in urine, is related 
to the ANP family and is involved with the regulation of natriuresis (61). Fielder et al 
studied urodilatin concentrations in intact and cardiac denervated dogs. This study 
found that urodilatin is primarily involved with renal Na+ regulation and has a closer 
relation to Na+ excretion than circulating ANP (27,31, 39, 31). The study also indicated 
that natriuretic peptides attenuate sympathetic nerves and contribute to hormone 
regulation (39). Unlike other types of ANP, urodilatin does not circulate in the blood 
(27,31). Natriuretic peptides are involved in the communication that occurs between 
cardiovascular and metabolic diseases, such as between hypertension and diabetes 
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(39). Urodilatin is used as a diagnostic tool for CVD and heart failure (75). Natriuretic 
peptide-mediated therapeutics are an important treatment for patients suffering from 
metabolic diseases and CVDs. Administration of ANP and ANP antagonists has 
demonstrated that ANP has antihypertrophic and antifibrotic functions. In some in vitro 
studies, rodents lacking natriuretic receptor-A (NPR-A) developed cardiac hypertrophy 
and fibrosis (53). Nishikimi et al found that ANP and BNP have a cardiac protective 
function (53). 
Hypertension Treatments- Pharmacological 
Prescribed antihypertensive drugs are very common in the medical world. Treatments 
for HT in stage 1 and stage 2 are mainly based on antihypertensive drugs. Treatments 
are individualized for patients who are suffering from other CVD, renal disease, or 
diabetes (57). The treatments also depend on the stages of hypertension and age (57). 
According to the American Heart Society (AHS) and the American College of Cardiology 
(ACC), for stage 1 HT, the systolic range remained between 130-139, or the diastolic 
BP range remained between 80-89. Stage 2 HT patients have systolic BP over 140 and 
diastolic over 90 (57). Target blood pressure is changed if other diseases conditions are 
present (3). For example, in patients with chronic kidney disease and diabetes, the 
target blood pressure will be 130/80 (3). 
Some common antihypertensive drugs are Thiazide -type diuretics, calcium channel 
blockers, ACE inhibitors and angiotensin 2 receptor blockers (ARBs). Thiazide diuretics, 
such as chlorthalidone and Indapamide, are a primary treatment for HT for all ages 
(3,26,25,57). Calcium channel blockers have been shown to reduce cardiovascular 
11 
 
mortality rates (57,76). These can be used as an alternative to diuretics (76). Some of 
the Ca++ channel blockers act as vasodilators (57,76,14). Ace inhibitors have shown 
effective cardiac protection for patients with kidney diseases and proteinuria. Ramipril is 
one of the most common ace inhibitors (76, 29). Beta-blockers are another 
antihypertensive drug. However, this drug has fewer protective effects in older patients 
(42). 
Antihypertensive drug therapies are not always successful in patients with underlying 
disease conditions. Diabetic patients have a high risk of getting hypertension because 
of altered carbohydrate metabolism (46). ACE inhibitors, angiotensin (types 1(AT1)) 
receptor blockers (ARBs), and calcium channel blockers are not always used to treat 
hypertensive patients with diabetes because antihypertensive drug usage is associated 
with harmful side effects. Conditions such as hyperkalemia are increased in patients 
with renal abnormalities, heart failure, and diabetes (57,46). Many hypertensive patients 
with diabetes require combined antihypertensive drug therapy to lower blood pressure 
(46, 43). Researchers observed that most drugs improved endothelial dysfunction. 
However, some drugs also improve plasma adiponectin and leptin levels as well 
Adiponectin has cardioprotective functions (43). Leptin is directly associated with 
adipose tissue and causes several cardiovascular complications. Plasma leptin levels 
are mainly responsible for stimulating vascular inflammation, oxidative stress, and 
vascular smooth muscle hypertrophy (43).  Leptin levels might responsible for diseases 
such as atherosclerosis, which is a major risk factor associate with hypertension. On the 
other hand, there were many complications associate with these drugs. Because of the 
excessive usage of anti-hypertensive drugs, side effects, and complexity of the drug 
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therapy, medical professionals have attempted to find alternative treatments (57,46). 
Minimal costs and side effects were associated with drug-free exercise training (50). 
Exercise and Cardiovascular Physiology 
Health professionals, ACC, and AHS also recommend lifestyle modifications such as 
daily exercise, for elevated blood pressure (57, 3,40). The American College of Sports 
Medicine (ACSM) found that at least 30 minutes of dynamic aerobic endurance exercise 
and resistance exercise per day helped to reduce elevated blood pressure in humans 
(1,40). Aerobic and regular physical activity reduces the risk of getting hypertension and 
other cardiovascular diseases. Studies also found that eight weeks of resistance or 
endurance training similarly reduce pre-hypertensive blood pressure and improved 
endothelial function in pre-hypertensive patients (6). There are different exercise 
training strategies and different types of exercise that help to reduce arterial pressure. 
Human studies have shown that exercise reduces systolic, diastolic, and mean arterial 
pressure (28,40). Exercise training sessions enhance endothelial function and decrease 
systolic and diastolic blood pressure by approximately 8-17 mmHg and 6-13 mmHg, 
respectively (1,6).  Resistance exercise leads to a reduction of resting SBP and DBP 
which reduces systemic and pulmonary blood pressure (6).   
In addition to lowering blood pressure, these studies found that aerobic training 
decreased central pulse wave velocity (PWV) and plasma aldosterone (Aldo) levels. 
Aerobic training in obese hypertensives has decreased plasma Aldo level and it was 
significantly correlated with PWV reduction(20). Increased Plasma Aldo level can 
stimulate RAAs and increase Na reabsorption which results in hypertension. PWV is 
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used to measure an individual’s arterial stiffness. Increase plasma aldosterone 
concentrations lead to greater PWV in hypertensive adults. An increase in blood 
pressure causes the vascular tone to increase. Exercise increases sympathetic activity, 
which results in increased cardiac output and an increased blood flow to the lungs (49). 
A recent study investigated the effect of resistance and aerobic exercise on central 
blood pressure and myocardial oxygen use in hypertensive and pre-hypertensive 
patients. The study found that exercise training reduces peripheral arterial stiffness and 
myocardial oxygen demand (7). Physical activity can increase blood flow to the kidneys, 
reduce urinary proteins, reduce renal inflammation, and inhibit fibrogenesis of the 
kidney (20,35).  Exercise reduces cardiovascular risk factors by decreasing blood 
pressure, improving lipid values, and reducing oxidative stress (35).  
It is clear that exercise training is beneficial to hypertensive patients, however, the exact 
physiological mechanism by which exercise is beneficial is unclear. Some studies 
supported that the effects of exercise training are due to reduced sympathetic activity 
and improved autonomic functions (77). Other studies suggest that exercise training is 
associated with neuronal plasticity in the brain area that regulates blood pressure (77). 
Moreover, exercise training reduces renal fibrosis in SHR and helps to prevent kidney 
damage (35). These studies found differences in the pathophysiology of kidney sections 
in SHR-sedentary and SHR-exercised groups, showing that renal fibrosis was 
significantly different between the SHR exercise and sedentary groups (35). 
It is crucial for the understanding of hypertension to investigate the physiological 
mechanisms underlying this disease and the mechanisms by which exercise can 
mitigate these effects. Exercise training can reduce visceral fat and improve Na+ 
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elimination by altering renal function. Exercise training increased blood flow to the renal 
interstitial which stimulates the pressure natriuresis mechanism.  Furthermore, 
elevations of blood pressure at the kidney also initiate decreased reabsorption of 
sodium in renal tubules, and high Na+ concentration in the urine (54). Exercise also 
alters kidney filtration by improving capillary hydrostatic pressure and increasing fluid 
exit into the renal interstitium. This results in greater Na+ excretion. Moreover, physical 
activity improves kidney functions, glomerular filtration capacity and contributes to 
improve Na+ excretion in normotensive and hypertensive subjects. Most studies on 
exercise and hypertension focus on aerobic exercise such as walking, running, 
swimming, and cycling (28).   
This Study 
Regular exercise has been reported to have benefits for the SHRs such as decreased 
blood pressure, reduced oxidative stress, reduced renal inflammation, and reduced 
fibrogenesis. However, the mechanisms for the decrease in blood pressure are not 
clear. A previous study in this lab found that voluntary exercise improved pressure 
natriuresis in a normotensive rat (WKY). Therefore, this study was designed to 
investigate the effects of voluntary exercise on pressure natriuresis in a hypertensive 
rat, the spontaneously hypertensive rat (SHR) (35). I hypothesized that exercise training 
will improve the pressure-natriuresis relationship (increase urinary sodium excretion 
with increases in renal perfusion pressure) in exercised female and male SHR rats. 
Exercised rats who allowed to exercise for 8-9 weeks will excrete more sodium for any 




Exercise Protocol:   
Twenty female SHR and twenty male SHR from our colony were weaned at 4 weeks of 
age and randomly assigned to the sedentary or exercise group. Exercised rats (10 male 
and 10 female) were housed individually with a 12-inch diameter stainless steel 
exercise wheel, with an attached wheel counter, to monitor wheel revolutions to 
determine the voluntary running distance. Sedentary rats (10 male and 10 female rats) 
were housed individually without running wheels.  Due to endemic respiratory disease in 
the rat colony, all study rats were treated with oral antibiotics (trimethoprim-sulfa @ 50 
mg/kg/day Trimethoprim and 250 mg/kg/day sulfa) to prevent lung diseases. Antibiotics 
were mixed with water for 10 days after assigned into groups. SHR-ex female and SHR-
ex male rats were allowed to exercise for at least 8 weeks before the acute study. The 
number of wheel revolutions was recorded twice weekly and converted to a weekly 
running distance in kilometers.   
Surgical Setup:   
Rats were weighed, then placed in an anesthetic chamber, and anesthetized with 
isoflurane gas (3%) in oxygen. Once asleep, rats were dosed with Inactin (100mg/kg) 
and allowed 10-15 minutes for the Inactin to take effect. Rats were monitored under 
anesthesia to avoid breathing difficulties, cardiac depression, or insufficient anesthesia. 
The rat’s ventral neck and abdomen, and medial region of each thigh were shaved 
using an electric clipper. Rats were then placed on a heating pad and a rectal 
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temperature probe was inserted. Rectal temperature was monitored and kept at 36ºC by 
adjusting the heating pad and using a heat lamp (on and off) when necessary. An 
incision was made in the ventral surface of the neck and a polyethylene tube was 
inserted into the trachea (PE 240) to assist with respiration. A saline and heparin (0.3 ml 
heparin-1000U/ml in 40ml saline solution) filled catheter (PE 50 attached to an adapter 
and a 3 way-stopcock) was inserted and tied into the isolated carotid artery. A pressure 
transducer in the catheter was connected to a computer for the measurement of blood 
pressure.   A saline filled catheter was inserted into the isolated jugular vein and 
connected to an infusion pump, which infused saline (20ml/kg/hour) to maintain body 
fluid balance. Next, an incision was made on the medial surface of the right thigh. The 
femoral artery was isolated, a heparin-saline filled catheter inserted (PE 20), tied in 
place, and a pressure transducer in the catheter was connected to the computer for 
measurement of renal perfusion pressure (RPP) during the low-pressure periods.   
A ventral midline incision was made in the abdomen and the intestines were moved to 
one side and wrapped in plastic wrap to keep them moist. The mesenteric and celiac 
arteries were isolated using gentle blunt dissection with cotton swabs and forceps, and 
a suture was looped around each artery as it exits the aorta.  The suture ends were 
pulled through a small piece of tubing (PE 190). Tightening the suture ends closed off 
these arteries to raise the renal perfusion pressure (RPP).  The aorta was isolated 
cranial to the renal arteries and caudal to the renal arteries, for later manipulation of 
RPP via aortic constriction.  
 The bladder was isolated, a small cut was made in the cranial edge, and a lipped 
urinary catheter (PE 240) was inserted and tied in place for urine collection. The screw 
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on the clamp was tightened or loosened to constrict or dilate the forceps to adjust RPP 
in a finely controlled manner.  Next, the exposed tissue was covered with saline-
moistened gauze, and the rat was allowed to equilibrate (rest) for 45 minutes.   BP 
recordings were collected briefly, every 10-15 minutes during this period to monitor 
catheter viability and blood pressure.  Starting surgery time, starting and ending saline 
infusion time, and saline infusion volume were recorded to ensure similar conditions for 
all rats.  
Data collection 
 After equilibration, blood pressure and heart rate were monitored continuously for the 
remainder of the study, via the carotid artery and femoral artery catheters, using 
computer-connected data collection hardware (Biopac). For every 15 minutes, urine 
was aspirated from the bladder catheter and bladder using a tuberculin 1ml (TB) syringe 
with an attached PE 50 tube.  Urine was placed into a TB syringe, measured, and 
covered with parafilm.  Samples were stored at 10 degrees C until analysis by flame 
photometer.  All urine collected between collection periods, when RPP was being 
adjusted, was discarded.  To determine the baseline values of blood pressure and urine 
sodium excretion, two fifteen-minute recordings with corresponding urine samples were 
taken. Baseline blood pressure was averaged for the two periods.  Then, the aortic 
clamp (forceps) was tightened (cranial to the renal arteries) until the blood pressure at 
the kidneys ( RPP) was 20 mmHg below the baseline mean, as measured by the 
femoral catheter.  Urine was collected over two additional 15-minute periods (low RPP).  
Next, the aortic clamp was released and the sutures around the celiac and mesenteric 
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arteries were tightened to increase blood pressure above the baseline mean by 30 
mmHg, measured via the carotid catheter. The aortic clamp was moved to a location 
caudal to the renal arteries.  The tension on the mesenteric suture and/or the aortic 
clamp was adjusted as needed to maintain the desired elevation in RPP. Urine was 
collected during three additional 15-minute periods (A third period was added due to a 
longer adjustment time in urinary Na+ excretion observed when RPP was raised, than 
when lowered. At the end of the acute study, a blood sample was drawn from the lower 
aorta using a TB syringe, and hematocrit was measured to check for appropriate 
hydration. Anesthetized rats were killed by the creation of a pneumothorax. The kidneys 
were removed and weighed. 
. 
Urine Analysis 
Parafilm-sealed urine samples were placed in a refrigerator until later analysis.  Urine 
samples less than 0.20 ml were diluted to 0.30 ml using double deionized (DDI) water to 
ensure adequate volume for analysis.  Those volumes of 0.20 ml or greater were diluted 
to a volume twice the original to be certain the sodium concentration did not exceed the 
recommended upper limit of the flame photometer. To meet the requirements of the 
flame photometer, each diluted original urine sample was diluted a second time, 1:200 
with DDI water, using an automated diluter.  Two of these dilutions were made for each 
urine sample, assuring sodium measurement in duplicate for each urine collection 
period.   Following the standard operating procedure, the flame photometer was 
calibrated using a standard 140 mmol/L Na+ solution, diluted 1:200 with DDI water.  
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Deionized water was aspirated to set the zero.   Once the Na+ ion concentration was 
determined, the two samples for each period were averaged, unless the two differed by 
more than 5%.  In this case, the original urine was reanalyzed. Overall, there were 14 
urine samples analyzed for each rat (a duplicate per each collection period).  The 
sodium excretion was calculated for each rat and period by multiplying the sodium 
concentration by the urine volume after the first dilution.  Group averages were 
calculated for each urine collection period. 
Data Analysis 
The urine sodium content was measured using a flame photometer.  Total sodium 
excretion was calculated for each of the samples by multiplying sodium concentration 
by the urine volume. For each rat group, urine sodium excretions ug/kg body weight/15 
minutes were plotted against the mean arterial pressure.  A pressure natriuresis curve 
was created by inserting a best-fit regression line for each group.  Differences between 
groups were determined by parallel line comparison or comparison of the y-intercepts.  
Heart rate and RPP data were measured using the Biopac software, and group means 
were calculated, for each 15 minutes period.  Wheel revolutions were converted into km 
and weekly means for males and females were plotted against weeks. Running 
distances,  RPP, initial urine volumes, and urine sodium excretion were compared using 
a two-way ANOVA with repeated measures. We have used equality variance test and 
normality test to identify the equality in the variance. Results are express as a mean +/- 
standard error. (Outliers were identified by values two standard deviations from the 
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mean, confirmed using a Grubbs test, and removed from the data).  Two sedentary 
males, one exercise male, and one sedentary female were removed 
Results 
General data 
Table 1 contains the general data for sedentary and exercised SHRs. Hypertensive 
sedentary and exercise rats of the same sex did not differ in age, length of time of the 
acute study, saline flow rate, hematocrit percentage, kidney weights or body weights. 
Male SHR kidney weights and body weights were greater than the female rats (One-
way Anova, p < 0.05)(Table 1).  
Running Distance 
Both male and female rats increased running distances from week 1 to week 4, 
however, the female rats ran an overall greater mean distance than the males (Figure 
1). Female rats ran greater distances than the male rats during individual weeks 4 and 6 
(Anova, p< 0.05)(figure 1). 
Renal Perfusion Pressure 
Baseline, lowered and raised RPP values were similar among the groups, (Figure 2) 
(Male SHR, ANOVA, df=18, Fstat=1.523, P value=0.233),( Female SHR, ANOVA, 
df=17, F stat=0.0213, P value=0.886). The change in RPP (∆RPP) from baseline, for all 
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raised and lowered RPP values, was also not different among the groups (Figure 3).        
( ANOVA, df=35, Fstat=0.187, P value=0.904.)  
 
Urine Volume 
In the sedentary groups and the exercise males, urine volume was increased over the 
baseline periods during all high periods. In the exercise female group, only high 2 and 
high 3 urine volumes were greater than baseline values. There was no difference 
between treatment groups of the same sex (Figure 4).( ANOVA, df=35, Fstat=1.866, P 
value=0.153). 
Urine Na excretion 
Exercised males increased urine sodium excretion over baseline during all high periods. 
Sedentary males had a greater urinary Na excretion than baseline in the high 2 and 
high3 periods. In the exercise females, urine Na excretion was increased in all high 
periods when compared to baseline values. Sodium excretion in the sedentary females 
increased over baseline in only the high 2 and high 3 periods. There was no difference 
in Na+ excretion among the four groups, and no differences were observed between 
treatment groups of same sex (Figure 5).(Male SHR, ANOVA, df=18, Fstat=1.280,  P 





Pressure Natriuresis Curves 
Pressure Natriuresis -Male:  Exercise had no significant effect on the pressure 
natriuresis curve in male rats. There was no statistical difference between the slope, or 
the Y-Intercept of the pressure natriuresis curve of the exercise males when compared 
to sedentary males (Figure 6).( Parallel line Analysis, F stat=0.046,  P value=0.8306) 
Test for equality of Intercepts, F stat=2.5155, P value=0.1150). 
Pressure Natriuresis-Female:  Exercise had a significant effect on the pressure 
natriuresis curve in female rats. The slope of the curve was greater in the exercised 
female rats than in the sedentary female rats (Figure 7).(Parallel line Analysis, F stat 
=10.3305, P=0.0017). 
Pressure Natriuresis-All Groups  
A sex difference was observed in the pressure natriuresis curves when like treated 
males and female rats were compared. Parallel line comparison and y intercept 
methods used to compare  slope differences The slope of sedentary males was 
significantly steeper than the sedentary females, and the Y-intercept of exercise males 
was significantly more negative than that of the exercise females (Figure 8). (Exercise 
males and exercise female - Parallel line analysis, F stat=1.0202, P value=0.3142, 
Equality of Intercept , F stat=11.5769, P value=0.0009). (Sedentary male and sedentary 






The major finding of this study was the difference in the pressure natriuresis curve of 
exercised female rats when compared to sedentary females.  Exercise females had an 
improved pressure natriuresis response, indicated by the steeper slope of the curve 
(Figure 7). This results in a greater increase in urine Na+ excretion for any given 
increase in RPP.  However, exercise males had no significant pressure natriuresis 
changes. The general data of this investigation, summarized in table 1, show no 
differences between the groups, except that the males were heavier, and had greater 
kidney weights than the female rats. Similar hematocrit percentages and saline infusion 
rates indicate similar levels of hydration among the groups, and thus cannot explain the 
lack of exercise effect in the male rats.   
There were no differences between renal perfusion pressure (RPP), or change in RPP 
from baseline, during any manipulation periods in sedentary and exercised rats (Figures 
2 and 3), indicating the RPP values and manipulations do not explain the change in the 
pressure natriuresis slope. Urine volumes and raw sodium excretion amounts were 
elevated above baseline values in all rats when RPP was raised, confirming that a 
pressure natriuresis response was stimulated.  Urine volume and sodium excretion was 
not different within the same sex, however, when RPP was raised, males had larger 
urine volume than females undergoing the same treatment, perhaps due to the larger 
size and blood volume. The effect of exercise was only evident when urinary sodium 
excretion was plotted against RPP, indicating the relationship between sodium excretion 
and RPP was altered. 
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Between sex, differences were noted when pressure natriuresis curves were compared 
between like treatment groups.  Sedentary males had a steeper slope than females, 
and exercised males had a more negative Y-intercept than exercised females.  These 
results suggest a more sensitive pressure natriuresis relationship in the male SHR than 
in the female.  It is unclear if the differences in pressure natriuresis in the sedentary 
males versus the females played a role in the lack of effect of exercise in the male SHR.  
Another potential explanation for a lack of exercise effect in the males is the lower 
running distances of the male rats, particularly noticeable during the earlier weeks when 
hypertension would be developing. The enhanced exercise performance of females 
compared with males, along with the difference in exercise effects, suggests that sex 
/gender difference in exercise performance may influence long-term pressure 
regulation. Previous studies in this laboratory showed that WKY females also had 
enhanced running performance compared to male WKY rats, but the difference in 
running distances was smaller.  Other studies have also shown that female rats had 
enhanced running performance over male rats (45, 41).  A sex difference in the effect of 
hypertension on renal functions/glomerular filtration rates, or endothelial function could 
modify the effects of exercise.  Researchers have determined sexually dimorphic 
characteristics to voluntary cage-wheel exercise in rats. Some cardiac morphological 
differences such as cardiac mass was significantly greater in female rats compared to 
males (45). The same study showed that females had a significantly greater increase in 
heart mass for every hour of activity than the male rats (45).  
Prior studies in Dr. Knoblich’s laboratory on normotensive WKY rats found that exercise 
improved pressure natriuresis in both males and females, and lowered baseline blood 
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pressure in anesthetized male, but not female WKY rats (Effects of voluntary exercise 
on pressure natriuresis in WKY rats).  In the WKY, exercise improved the slope of the 
pressure natriuresis curve in both female and male rats when compared to sedentary 
groups. Some sex differences were found when comparing treatments between the 
sexes in WKY rats. Sedentary females had a more negative Y-intercept than sedentary 
males, and exercised females had a steeper slope than exercised males.  When 
compared to the WKY rats, the sex differences in the pressure-natriuresis curves of the 
SHR in the current study were reversed, with the sedentary males showing a greater 
slope than females, and exercise males having a more negative Y-intercept than 
females. The difference in exercise effects in the SHR, when compared to the WKY, 
may be the result of physiological alterations due to hypertension.   
The mechanism by which exercise improved pressure natriuresis is unclear.  Running 
and swimming appear to improve endothelial function (74,6). After 8 weeks of training, 
the dilation of the brachial artery when blood flow increases (flow-mediated dilation or 
FMD) was changed. However, there was no difference in the response between males 
and females (6). NO release from the endothelial cell is one of the main causes of FMD. 
Endothelial dysfunction is often found in hypertensive patients. Endothelial dysfunction 
can cause abnormalities in vessel walls including renal arteries, and this dysfunction is 
linked to many renal diseases including renal fibrosis, which is prevalent in hypertensive 
individuals (74,6). The production of nitric oxide by healthy endothelium is believed to 
be a key factor in the pressure natriuresis response. Continuous development of renal 
medullary oxidative stress causes kidney dysfunctions (54). NO may play a major role in 
Na+ excretion and in modulating the pressure natriuresis response in hypertensive rats, 
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which have lower levels of NO (54).  One study found that continuous NO production 
was required to prevent the development of cardiovascular diseases like hypertension 
because NO can stimulate renal blood flow. Inhibition of NO production results in 
reduced renal medullary blood flow (54). NO acts as a signal to reduce tubular sodium 
reabsorption which increases Na+ excretion in normotensive rats. The authors 
concluded that reduced renal blood flow influences sodium excretion in hypertensive 
rats (54). These findings suggest that NO plays a major role in maintaining pressure 
natriuresis, and improvements in endothelial function with exercise could increase NO 
synthesis and pressure natriuresis. 
  Exercise can have beneficial effects on other aspects of kidney function. Glomerular 
blood flow regulation and glomerular filtration rate/ capacity are the main factors 
associated with body fluid regulation, and these are negatively impacted by 
hypertension (11,74). Juxtamedullary nephrons of normotensive rats tend to remain 
healthy, however, in SHR, the juxtamedullary complex is complicated and has an 
increased risk of pathological lesions such as fibrinoid necrosis, fibro sclerosis, and 
glomerulosclerosis (11,74). Moreover, filtration is not normal in the cortical nephrons of 
the SHR (74). In contrast to normotensive rats, the renal medulla can be damaged 
under hypertensive conditions.  Experiments in animal models have shown the benefits 
of exercise for kidney disease associated with CVD. Renal inflammation kidney 
diseases always follow cardiovascular diseases. Glomerulosclerosis was reduced in 
swim exercised rats when compared to sedentary rats. Glomerular filtration rates were 
increased in female and male exercised groups compared to sedentary groups (74). 
Another study found that the systolic blood pressure and renal fibrosis in hypertensive 
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rats improved after exercise training (36). Moreover, exercise groups had a decrease in 
inflammatory protein levels, fibrotic-related protein levels, and connecting tissue growth 
factors (36, 74). These factors are a major part of renal diseases which can affect the 
kidney filtration capacity and glomerular filtration rate in hypertensive rats. Like our SHR 
kidney weights, there was no difference in kidney weights between groups in a study 
conduct by C. Huang. However, this study histologically analyzed the kidneys and found 
SHR had enlarged areas of fibrosis when compared with WKY groups. SHR-exercised 
rats had a significant decrease in renal fibrosis (36).  
Sex differences in the effects of hypertension produce different outcomes in males and 
females. Hypertensive males experience more oxidative stress than hypertensive 
females, and males also experience abnormal pressure natriuresis due to high oxidative 
stress (70). Researchers examined the influence of sex hormones on renal oxidative 
stress in hypertension because oxidative stress due to reactive oxygen species plays an 
important role in renal pressure natriuresis. Reactive oxygen species such as hydrogen 
peroxide can result in abnormal Na+ handling, and Na+ excretion in hypertensive 
individuals by reducing renal blood flow (70). Research conducted by J Sullivan et al 
found that male SHRs have increased urinary H2O2 excretion compared to females 
(70). Estrogen suppresses reactive oxygen species, and testosterone stimulates 
reactive oxygen species, leading to sexual dimorphism in hypertensive rats (70).  
Young women have estrogen receptors in many tissues and cells, including vessels, 
muscles, endothelial cells, and myocardial cells, while premenopausal women have 
fewer estrogen receptors in the same tissues (66). Some population-based studies 
demonstrated that postmenopausal women have a high risk of getting cardiovascular 
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diseases. The authors suggest that postmenopausal women who carry ESR1 ( estrogen 
receptor) have an increased risk of myocardial infarction and other CVD (66). Exercise 
and estrogen also maintain normal myosin patterns in slow and fast muscle (41). 
Female sex hormones have a strong effect on cardiovascular functions and 
musculoskeletal functions (41). 
Hypertensive patients often have elevated levels of vasoconstrictive agents, such as 
vasopressin, and angiotensin II (54). Vasoconstrictor hormones such as angiotensin, 
increase Na+ reabsorption in hypertensive rats.  Furthermore, many studies involve the 
renin-angiotensin-aldosterone system (RAAS) in hypertensive rats because the RAAS 
is the other long-term regulator of blood pressure that is involved with hormones. 
Female sex hormones and estrogen receptors in endothelial cells can regulate this 
RAAS activity. A study by Nickenig et al demonstrated that Ang II caused significantly 
stronger vasoconstriction in ovariectomized rats, supporting the idea that there is a 
strong correlation between sex hormones and the RAAS  (52). Female sex hormones 
have protective cardiovascular effects and estrogen therapies have been used to 
prevent CVD. Estrogen therapy reduces the risk of coronary heart disease because it 
can reduce coronary artery angiotensin (angiotensin-converting enzyme) activity (71). 
Estrogen therapy also increases cardiac atrial natriuretic peptide (ANP) in circulating 
blood which acts as a vasodilator and promotes natriuresis (65). 
The male sex hormone testosterone also contributes to sex differences in SHRs. 
Studies by Jane et al showed that testosterone increases the risk of hypertension in 
male SHR via the RAAS (64). Plasma renin concentration is high in males compared to 
females (67). Renin converts angiotensinogen to angiotensin I, which subsequently gets 
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converted to angiotensin II. Ovariectomized female rodents treated with testosterone 




Our hypothesis was partially correct.  Our results support the idea that exercise, as a 
non-pharmacological treatment,  improves the pressure natriuresis response in female 
hypertensive rats. In males, the natriuresis response was not improved, possibly due to 
sex differences in the effects of exercise, other physiological factors, or differences in 
running distances. It is unclear if greater running distances early in hypertension 
development would result in similar effects in the males.  Because hypertension results 
in endothelial dysfunction and progressive renal damage, it is not surprising that some 
of the benefits of exercise on hypertension may be within the kidneys.  The exact 
mechanism by which pressure natriuresis was altered in the exercised rats is unclear, 
but improved endothelial function and nitric oxide production, resulting in less renal 
fibrosis, and improved renal function, remains a possibility. Identifying the specific 
mechanisms could support the development of therapeutic strategies for hypertension 






The exact mechanism and mediators behind the alterations in pressure natriuresis 
should be determined.   Further examination of gender differences associated with 
pressure natriuresis, and the effects of sex hormones combined with exercise on 
pressure natriuresis in female and male SHR and WKY rats would also be beneficial. 
 

















                                  Table and Figures 
 
Table 1: General data from sedentary and exercise SHRs.  Age at the time of the 
study, acute study total time, saline infusion rate (flow rate), hematocrit, kidney weight, 













16.43 ± 0.90 6.46 ± 0.32 19.05 ± 1.15 67.20 ± 2.59 2.60 ± 0.08* 0.32 ± 0.011* 
Exercise 
Male 
17.65 ± 0.74 5.99 ± 0.23 18.64 ± 0.83 62.10 ± 2.89 2.90 ± 0.05* 0.36 ± 0.011* 
Sedentary  
Female 
16.91 ± 1.01 5.41 ± 0.25 25.96 ± 1.34 62.67 ± 1.14 1.59 ± 0.03 0.21 ± 0.004 
Exercise 
Female 
16.67 ± 0.46 6.12 ± 0.28 22.06 ± 1.06 62.00 ± 3.21 1.85 ± 0.04 0.23 ± 0.004 
 





Figure 1:  Weekly running distances in male and female SHR. Values are mean ± SE.  † p < 
0.05 when compared to the male rats.  
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Figure 2: Renal perfusion pressure (RPP) during baseline (BL), lowered (low), and raised 
(high) manipulations in sedentary and exercised male and females SHR. Values are mean ± SE. 
Renal Perfusion Pressure
Manipulation Period
































Sedentary M (n=10) 
Exercise M (n=10) 
Sedentary F (n=9) 




Figure 3: Change from baseline in renal perfusion pressure during lowered (low) and raised 
(high) manipulations in sedentary and exercised male and female SHR. Values are mean ± SE. 
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Figure 4: Mean urine volume during baseline (BL), lowered (low), and raised (high) 
manipulations of renal perfusion pressure in sedentary and exercised male and female SHR. 
Values are mean ± SE. *P < 0.05 when compared to baseline  
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Figure 5: Urine sodium excretion during baseline (BL), lowered (low), and raised (high) 
manipulations of renal perfusion pressure in sedentary and exercised male and female SHR. 
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Figure 6: Pressure natriuresis curves in sedentary and exercised male SHR. Neither the slope or 
the Y-intercept was different between the groups. 
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Figure 7: Pressure natriuresis curves in sedentary and exercised female SHR.   † P < 0.05 when 
compared to the slope of the natriuresis curve of the sedentary rats.   
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Figure 8: Pressure natriuresis curves in sedentary and exercised, male and female SHR.  
† P < 0.05 when the slope is compared to that of the female rats of the same treatment.   
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